Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-8 of 8
Keywords: Losartan
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Journal:
Kidney and Blood Pressure Research
Kidney Blood Press Res (2015) 40 (4): 374–385.
Published Online: 07 July 2015
... long-acting drugs: perindopril and losartan in the treatment of hypertension comparing the once-daily (evening) vs. twice-daily (morning and evening) administration with the same daily doses. Methods: Untreated primary hypertensive patients without complaints (a total of 164: 65 men, 99 women, 55.7...
Journal Articles
Jiao Qin, Wen-Juan Mei, Yan-Yun Xie, Ling Huang, Qiong-Jing Yuan, Gao-Yun Hu, Li-Jian Tao, Zhang-Zhe Peng
Journal:
Kidney and Blood Pressure Research
Kidney Blood Press Res (2015) 40 (1): 89–99.
Published Online: 05 March 2015
... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Fluorofenidone Obstructive nephropathy NOX2 (gp91phox) ERK Losartan Upper...
Journal Articles
Hajime Hasegawa, Yosuke Tayama, Kaori Takayanagi, Juko Asakura, Toru Nakamura, Kenji Kawashima, Taisuke Shimizu, Takatsugu Iwashita, Tomonari Ogawa, Akihiko Matsuda, Tetsuya Mitarai
Journal:
Kidney and Blood Pressure Research
Kidney Blood Press Res (2013) 37 (6): 521–530.
Published Online: 16 November 2013
...Hajime Hasegawa; Yosuke Tayama; Kaori Takayanagi; Juko Asakura; Toru Nakamura; Kenji Kawashima; Taisuke Shimizu; Takatsugu Iwashita; Tomonari Ogawa; Akihiko Matsuda; Tetsuya Mitarai Background/Aims: This multicenter, prospective, observational study assessed the renoprotective effects of losartan...
Journal Articles
Fosinopril and Losartan Regulate Klotho Gene and Nicotinamide Adenine Dinucleotide Phosphate Oxidase Expression in Kidneys of Spontaneously Hypertensive Rats
Available to Purchase
Journal:
Kidney and Blood Pressure Research
Kidney Blood Press Res (2011) 34 (5): 350–357.
Published Online: 03 June 2011
... Klotho and oxidative stress. The present studies were performed to explore effects of fosinopril (Fos) and losartan (Los) on Klotho and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase expression in kidneys of spontaneously hypertensive rats (SHR). Methods: Twenty-four male 22-week-old SHR...
Journal Articles
Renoprotection Provided by Losartan in Combination with Pioglitazone Is Superior to Renoprotection Provided by Losartan Alone in Patients with Type 2 Diabetic Nephropathy
Available to Purchase
Journal:
Kidney and Blood Pressure Research
Kidney Blood Press Res (2007) 30 (4): 203–211.
Published Online: 15 June 2007
...Hui Min Jin; Yu Pan Aim: This study was performed to ascertain whether losartan combined with pioglitazone is superior to losartan alone in delaying the progression of chronic renal failure in patients with type 2 diabetic nephropathy. Methods: Sixty patients with type 2 diabetic nephropathy (stage...
Journal Articles
Antiproteinuric Effect of Losartan in Non-Diabetic Renal Disease Is Not Dependent on ACE Insertion/Deletion Polymorphism
Available to PurchaseHyeong Cheon Park, Hoon Young Choi, Beom Seok Kim, Shin Wook Kang, Kyu Hun Choi, Sung Kyu Ha, Ho Yung Lee, Dae Suk Han
Journal:
Kidney and Blood Pressure Research
Kidney Blood Press Res (2006) 29 (4): 216–224.
Published Online: 17 November 2006
... nephropathy. This interaction may be overcome by using an angiotensin II receptor blocker. We evaluated the short-term antiproteinuric effect of losartan according to the ACE I/D genotype in patients with non-diabetic proteinuric renal diseases. Methods: Ninety-nine (II/ID/DD: 36/52/11) non-diabetic patients...
Journal Articles
Effects of Angiotensin II and the AT 1 Receptor Antagonist Losartan on the Renal Excretion of Urodilatin
Available to Purchase
Journal:
Kidney and Blood Pressure Research
Kidney Blood Press Res (2001) 24 (2): 79–83.
Published Online: 29 June 2001
... perfusion pressure. This suggests a relationship between urodilatin and the renin-angiotensin system. Methods: We investigated the effects of angiotensin II (AII, 0.1 nmol/l) and the AT 1 receptor antagonist losartan (LS, 1 µmol/l) on U URO V and renal function in isolated rat kidneys perfused for 180 min...
Journal Articles
Effects of the AT1 Antagonist HR 720 in Comparison to Losartan on Stimulated Sympathetic Outflow, Blood Pressure, and Heart Rate in Pithed Spontaneously Hypertensive Rats
Available to Purchase
Journal:
Kidney and Blood Pressure Research
Kidney Blood Press Res (1998) 21 (1): 29–35.
Published Online: 17 June 1998
...-animal model, which reflects the peripherally sympathetic system (pithed rat), was investigated. Furthermore, the effects of a new AT 1 antagonist, HR 720, are demonstrated with respect to its pre- and postsynaptic actions in comparison to the AT 1 antagonist losartan. Dose-response curves to angiotensin...
